<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To test possible differences between patients with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and patients with other forms of <z:hpo ids='HP_0000726'>dementia</z:hpo> and the healthy population concerning body composition, blood pressure, metabolic data and leukoaraiosis (LA) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Retrospective study on data collected according to a predefined protocol </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: A geriatric, neuropsychiatric diagnostic unit </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: Seventy-one consecutive patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>MAIN OUTCOME MEASURES: Body mass index, blood pressure, metabolism and LA in AD compared to other <z:hpo ids='HP_0000726'>dementia</z:hpo> forms </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mean blood pressure and fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels were lower in patients with AD, 94 +/- 12 mmHg and 4.3 +/- 0.5 mmol l-1, compared to patients with unspecified <z:hpo ids='HP_0000726'>dementia</z:hpo> (NUD), 100 +/- 10 mmHg and 5.5 +/- 2.5 mmol l-1 (P &lt; 0.05) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VAD), 114 +/- 12 mmHg and 5.6 +/- 1.6 mmol l-1 (P &lt; 0.001) and the age-matched healthy population </plain></SENT>
<SENT sid="6" pm="."><plain>Body mass index, serum cholesterol and <z:chebi fb="1" ids="17650">cortisol</z:chebi> were similar in <z:hpo ids='HP_0000001'>all</z:hpo> groups of <z:hpo ids='HP_0000726'>dementia</z:hpo> patients whereas <z:chebi fb="4" ids="17855">triglycerides</z:chebi> were highest in the VAD group </plain></SENT>
<SENT sid="7" pm="."><plain>No cases of <z:mp ids='MP_0002055'>diabetes</z:mp> or treatment for <z:hpo ids='HP_0000822'>hypertension</z:hpo> were found in the AD group while the prevalence was 21% and 36% for <z:mp ids='MP_0002055'>diabetes</z:mp> in the NUD and VAD groups and 8% in the population from the same region </plain></SENT>
<SENT sid="8" pm="."><plain>There were 16% with <z:chebi fb="0" ids="35674">antihypertensive</z:chebi> treatment in <z:hpo ids='HP_0000726'>dementia</z:hpo> NUD, 50% in VAD, and 30% in the general population </plain></SENT>
<SENT sid="9" pm="."><plain>Treated or newly detected hypothyreosis was present in 11% of the AD patients, none in the other <z:hpo ids='HP_0000726'>dementia</z:hpo> groups and 2% in the general population </plain></SENT>
<SENT sid="10" pm="."><plain>Smoking was least common in AD </plain></SENT>
<SENT sid="11" pm="."><plain>Degree of LA correlated with blood pressure and blood <z:chebi fb="105" ids="17234">glucose</z:chebi> levels </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: AD was clearly different to other <z:hpo ids='HP_0000726'>dementia</z:hpo> patients </plain></SENT>
<SENT sid="13" pm="."><plain>They had lower blood pressure, blood <z:chebi fb="105" ids="17234">glucose</z:chebi> and higher prevalence of hypothyreosis than the healthy, age-matched population </plain></SENT>
<SENT sid="14" pm="."><plain>These findings may indicate that AD could be a hypometabolic disorder </plain></SENT>
</text></document>